All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date, and reported results | 2004-002887-41 | Randomisierte, kontrollierte, für den Prüfer verblindete klinische Prüfung (Pilotstudie) zur Untersuchung der Wirksamkeit von Spersadex® Augentropfen im Vergleich zu Isopto®-Dex Augentropfen bei Patie... | bad-data | |
Completed, but no date, and reported results | 2004-002889-38 | Randomisierte, kontrollierte, doppelblinde klinische Prüfung zur Untersuchung der Wirksamkeit und Verträglichkeit von Novesine® 0,4% Augentropfen im Vergleich zur Augentropfengrundlage bei zur Tonomet... | bad-data | |
Reported results | 2011-002601-30 | A COMPARISON OF LATANOPROST 50µg/ml EYE DROPS vs. XALATAN EYE DROPS IN THE TREATMENT OF OPEN ANGLE GLAUCOMA: AN OPEN, RANDOMIZED, CLINICAL TRIAL COMPARACION DE LATANOPROST 50μg/ml COLIRIO vs. XALA... | 2013-06-04 | due-trials |
Completed, but no date, and reported results | 2011-005339-15 | Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of the Fixed Combinati... | bad-data | |
Reported results Terminated | 2012-000026-22 | Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of Travoprost 40 µg/ml... | 2015-10-06 | due-trials |
Reported results Terminated | 2012-000044-10 | Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of the Fixed Combinati... | 2017-03-13 | due-trials |
Reported results | 2013-003083-31 | Open, Observer-blind, two Parallel Group, Randomized, Multicentric Clinical Phase III Trial on the Comparison of Efficacy and Tolerability of a New Preservative-free Formulation of Brimonidine 2 mg/ml... | 2014-12-12 | due-trials |
Reported results | 2014-002576-91 | Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic Formulation of Travoprost 40μg/ml... | 2015-12-18 | due-trials |
Reported results | 2015-000160-34 | Therapeutic Equivalence (non-inferiority), Randomized, Observer-blind, two Parallel Group, Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic Formulation of 0.2% Brimonidine/0... | 2016-06-17 | due-trials |
Reported results Terminated | 2015-005314-29 | Randomized, open-label, two parallel group clinical trial, conducted under blinding evaluator conditions to compare the efficacy and tolerability of preservative-free formulation of Latanoprost 50µg/m... | 2016-10-27 | due-trials |